Paris: Sanofi has announced that the US Food and Drug Administration (FDA) has approved Dupixent (dupilumab) as an add-on ...

Bristol Myers gains FDA approval for a new schizophrenia drug. HHS declares a health emergency in Georgia due to Hurricane ...

The US Food and Drug Administration (FDA) on Friday approved Dupixent (dupilumab) as an add-on maintenance treatment of ...

This summary of current health news includes FDA approvals for new drugs by Bristol Myers and GE HealthCare, public health ...

The CNBC host said that he has reminded his viewers repeatedly that when the Fed is your “enemy” you should stick to ...

Kepler Capital analyst David Evans maintained a Buy rating on Roche Holding AG (RHHVF – Research Report) on September 26 and set a price ...

Significant regulatory news last week included the US Food and Drug Administration (FDA) granting approval for Zevra ...

Portfolio manager Cathie Wood's Ark Innovation ETF (NYSEMKT: ARKK) loaded up on a pair of biotech stocks throughout August and early September, and it wasn't the first time they caught her attention.

Regeneron's R&D expenses are projected to reach $5 billion, but the business remains highly profitable. Read why I rate REGN ...

In November 2021, Sanofi made a similar – but not its first – investment in AI, taking a $180 million equity stake in Franco-US start-up Owkin with another $90 million in funding for a ...

Third quarter 2024 results will be reviewed by management during a live audio webcast with the financial community. The presentation will be followed by a Q&A session. Third quarter 2025 results will ...

Seven labourers from Punjab were killed by unidentified gunmen in Balochistan's Panjgur town. One worker was injured. This incident follows a series of violent events in August involving ...